Thursday, March 14, 2013
Discovery Partnerships with Academia program has struck new deals with
laboratories at the Vanderbilt University School of Medicine and The Hospital for Sick Children to
identify compounds for severe obesity and cystic fibrosis, respectively. The
partnerships aim to re-examine previously known targets in light of new
structural and functional insights.
Osherovich, L. SciBX 6(10); doi:10.1038/scibx.2013.230
Published online March 14, 2013
AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K.
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K.
The Hospital for Sick Children, Toronto, Ontario, Canada
Palatin Technologies Inc. (NYSE-M:PTN), Cranbury, N.J.
University of Toronto, Toronto, Ontario, Canada
Vanderbilt University School of Medicine, Nashville, Tenn.
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Cambridge, Mass.